Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11276
PUT
Yext
YEXT
$594M
| $67.7K | ﹤0.01% |
10,700
-10,600
| -50% | -$90.6K |
|
11277
PUT
Protalix BioTherapeutics
PLX
$179M
| $67.7K | ﹤0.01% |
40,800
+6,300
| +18% | +$11.3K |
|
11278
CALL
Ooma
OOMA
$572M
| $67.7K | ﹤0.01% |
5,200
+4,700
| +940% | +$66.5K |
|
11279
PUT
CEL-SCI Corp
CVM
$26.9M
| $67.6K | ﹤0.01% |
1,803
-437
| -20% | -$20.9K |
|
|
TPIC
11280
PUT
DELISTED
TPI Composites
TPIC
| $67.6K | ﹤0.01% |
25,500
-7,500
| -23% | -$45.9K |
|
|
HSII
11281
CALL
DELISTED
Heidrick & Struggles
HSII
| $67.6K | ﹤0.01% |
2,700
-700
| -21% | -$18.7K |
|
|
HITI
11282
PUT
High Tide
HITI
$206M
| $67.5K | ﹤0.01% |
36,500
+6,500
| +22% | +$9.29K |
|
11283
CALL
Pacira BioSciences
PCRX
$917M
| $67.5K | ﹤0.01% |
2,200
-4,900
| -69% | -$177K |
|
11284
OppFi
OPFI
$610M
| $67.5K | ﹤0.01% |
+26,781
| New | +$62.3K |
|
11285
Vanguard Morningstar Growth ETF
VUG
$230B
| $67.3K | ﹤0.01% |
1,482
-262,464
| -99% | -$12.4M |
|
11286
PUT
Maximus
MMS
$2.89B
| $67.2K | ﹤0.01% |
900
-2,300
| -72% | -$187K |
|
11287
CALL
Dyadic International
DYAI
$28.2M
| $67.2K | ﹤0.01% |
35,000
-8,900
| -20% | -$16.6K |
|
|
FFAI
11288
CALL
Faraday Future Intelligent Electric
FFAI
$10M
| $67K | ﹤0.01% |
+3
| New | +$777K |
|
|
IAUX
11289
i-80 Gold Corp
IAUX
$1.45B
| $67K | ﹤0.01% |
43,760
+13,745
| +46% | +$26.9K |
|
11290
CALL
iShares Self-Driving EV and Tech ETF
IDRV
$139M
| $66.9K | ﹤0.01% |
1,800
+1,100
| +157% | +$44.7K |
|
11291
PUT
Dr. Reddy's Laboratories
RDY
$10.2B
| $66.9K | ﹤0.01% |
5,000
+4,000
| +400% | +$54.1K |
|
|
KAMN
11292
PUT
DELISTED
Kaman Corp
KAMN
| $66.8K | ﹤0.01% |
3,400
+2,600
| +325% | +$58K |
|
|
DSL
11293
PUT
DoubleLine Income Solutions Fund
DSL
$1.24B
| $66.8K | ﹤0.01% |
5,700
-10,600
| -65% | -$127K |
|
11294
PUT
First Hawaiian
FHB
$3.37B
| $66.8K | ﹤0.01% |
3,700
-4,800
| -56% | -$92.5K |
|
|
ASA
11295
PUT
ASA Gold and Precious Metals
ASA
$1.1B
| $66.7K | ﹤0.01% |
5,000
+400
| +9% | +$5.9K |
|
11296
CALL
X4 Pharmaceuticals
XFOR
$418M
| $66.6K | ﹤0.01% |
2,037
-5,030
| -71% | -$219K |
|
11297
PUT
Live Oak Bancshares
LOB
$2B
| $66.6K | ﹤0.01% |
2,300
-7,700
| -77% | -$248K |
|
11298
CALL
RPAR Risk Parity ETF
RPAR
$582M
| $66.5K | ﹤0.01% |
+3,800
| New | +$71K |
|
11299
Broadway Financial
BYFC
$111M
| $66.5K | ﹤0.01% |
8,481
-1,891
| -18% | -$14.4K |
|
11300
Grupo Aval
AVAL
$6.29B
| $66.5K | ﹤0.01% |
+27,464
| New | +$67.1K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.